Literature DB >> 25318605

Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study.

Heng Zhang1, Chunhe Liu, Yu-Chen Han, Zuohong Ma, Haiyan Zhang, Yinan Ma, Xiaofang Liu.   

Abstract

Hepatocellular carcinoma (HCC) is the sixth common cancer and the third common cause of cancer mortality worldwide. However, the exact molecular mechanism of HCC remains uncertain. Many enzymes are involved in one-carbon metabolism (OCM), and single nucleotide polymorphisms (SNPs) in the corresponding genes may play a role in liver carcinogenesis. In this study, we enrolled 1500 HCC patients and 1500 cancer-free controls, which were frequency-matched by age, gender, and HBV infection status. Then eight SNPs from seven OCM genes (MTHFR, MTR, MTRR, FTHFD, GART, SHMT, and CBS) were evaluated. Results showed that six SNPs (MTHFR rs1801133, MTRR rs2287780, MTRR rs10380, FTHFD rs1127717, GART rs8971, and SHMT rs1979277) were significantly associated with HCC risk in Chinese population, with P values range from 2.26 × 10(-4) to 0.035). The most significant association was detected for GART rs8971. Compared with individuals with the TT genotype, the age- and sex-adjusted odds ratio (OR) for developing HCC was 1.44 (95% confidence interval (CI): 1.03-2.02) among those with the CC genotype and 1.30 (95% CI: 1.10-1.53) for those with CT genotype. Under the log-additive model, each additional copy of minor allele C was associated with a 1.28-fold increased risk of HCC (OR = 1.28, 95% CI: 1.12-1.45). These findings indicated that genetic variants in OCM genes might contribute to HCC susceptibility.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318605     DOI: 10.1007/s13277-014-2725-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.

Authors:  Peipei Song
Journal:  Biosci Trends       Date:  2013-10       Impact factor: 2.400

2.  Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.

Authors:  Xiaosheng Qi; Xing Sun; Junming Xu; Zhaowen Wang; Jinyan Zhang; Zhihai Peng
Journal:  Tumour Biol       Date:  2014-01-03

3.  Molecular phylogenetic analysis of methylenetetrahydrofolate reductase family of proteins.

Authors:  Murat Kasap; Ali Sazci; Emel Ergul; Gurler Akpinar
Journal:  Mol Phylogenet Evol       Date:  2006-10-07       Impact factor: 4.286

4.  Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity.

Authors:  Mitchell P Rosen; Shehua Shen; Charles E McCulloch; Paolo F Rinaudo; Marcelle I Cedars; Anthony T Dobson
Journal:  Fertil Steril       Date:  2007-06-18       Impact factor: 7.329

5.  Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

Authors:  Hang Su; Jing Zhao; Yujuan Xiong; Teng Xu; Fan Zhou; Yunfei Yuan; Ying Zhang; Shi-Mei Zhuang
Journal:  Mutat Res       Date:  2008-02-14       Impact factor: 2.433

6.  Endoplasmic reticulum stress increases the expression of methylenetetrahydrofolate reductase through the IRE1 transducer.

Authors:  Daniel Leclerc; Rima Rozen
Journal:  J Biol Chem       Date:  2007-12-07       Impact factor: 5.157

7.  Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.

Authors:  Lesley M Butler; Erland Arning; Renwei Wang; Teodoro Bottiglieri; Sugantha Govindarajan; Yu-Tang Gao; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-29       Impact factor: 4.254

8.  Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.

Authors:  Pierluigi Toniutto; Carlo Fabris; Edmondo Falleti; Annarosa Cussigh; Elisabetta Fontanini; Davide Bitetto; Ezio Fornasiere; Rosalba Minisini; Tullia De Feo; Francesca Marangoni; Mario Pirisi
Journal:  Liver Int       Date:  2007-09-26       Impact factor: 5.828

9.  Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.

Authors:  Li-Na Mu; Wei Cao; Zuo-Feng Zhang; Lin Cai; Qing-Wu Jiang; Nai-Chieh You; Binh Yang Goldstein; Guo-Rong Wei; Chuan-Wei Chen; Qing-Yi Lu; Xue-Fu Zhou; Bao-Guo Ding; Jun Chang; Shun-Zhang Yu
Journal:  Cancer Causes Control       Date:  2007-05-15       Impact factor: 2.506

10.  Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Authors:  Dongyun Yang; Diana L Hanna; Josh Usher; Jordan LoCoco; Pritesh Chaudhari; Heinz-Josef Lenz; V Wendy Setiawan; Anthony El-Khoueiry
Journal:  Cancer       Date:  2014-07-31       Impact factor: 6.921

View more
  12 in total

1.  The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.

Authors:  C Wang; H Xie; D Lu; Q Ling; P Jin; H Li; R Zhuang; X Xu; S Zheng
Journal:  Clin Transl Oncol       Date:  2017-11-28       Impact factor: 3.405

Review 2.  Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.

Authors:  Sergey A Krupenko; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2019-02-20       Impact factor: 5.192

3.  Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.

Authors:  Tingting Zhao; Dongying Gu; Zhi Xu; Xinying Huo; Lili Shen; Chun Wang; Yongfei Tang; Peng Wu; Jason He; Weida Gong; Ming-Liang He; Jinfei Chen
Journal:  Oncotarget       Date:  2015-04-20

4.  Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma.

Authors:  Nathália Perpétua Peres; Ana Lívia Silva Galbiatti-Dias; Márcia Maria Urbanin Castanhole-Nunes; Renato Ferreira da Silva; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo; Mariangela Torreglosa Ruiz-Cintra
Journal:  World J Hepatol       Date:  2016-10-18

5.  Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.

Authors:  Julia Krushkal; Yingdong Zhao; Curtis Hose; Anne Monks; James H Doroshow; Richard Simon
Journal:  Clin Epigenetics       Date:  2016-06-24       Impact factor: 6.551

6.  Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population.

Authors:  Yuan-Yuan Qu; Shu-Xian Zhou; Xuan Zhang; Rui Zhao; Cheng-Yuan Gu; Kun Chang; Xiao-Qun Yang; Hua-Lei Gan; Bo Dai; Hai-Liang Zhang; Guo-Hai Shi; Yao Zhu; Ding-Wei Ye; Jian-Yuan Zhao
Journal:  Sci Rep       Date:  2016-11-03       Impact factor: 4.379

7.  Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.

Authors:  Chao Li; Juan Ni; Yao-Xian Liu; Han Wang; Zi-Qing Liang; Xu Wang
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

8.  Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.

Authors:  Yanhui Shi; Weiyu Zhai; Bin Wang; Dongmei Zhao; He Jin; Yuefei Wang; Jidong Zhang; Hongjun An; Zhongze Fu; Kun Zhao; Changzhu Lu
Journal:  Oncotarget       Date:  2016-12-06

9.  Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.

Authors:  Sheng Zhang; Jiakai Jiang; Weifeng Tang; Longgen Liu
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

10.  Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Front Oncol       Date:  2020-07-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.